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Objective: We investigated survival and predictors of mortality for infants and chil-
dren with heart disease treated with extracorporeal membrane oxygenation as an
aid to cardiopulmonary resuscitation.
Methods: Children (,18 years) with heart disease who received extracorporeal car-
diopulmonary resuscitation and were reported to the Extracorporeal Life Support Or-
ganization database were evaluated. Patients were classified into one of 3 groups
based on underlying cardiac physiology: single ventricle, 2 ventricles, and cardiac
muscle disease. Patients with eligible procedure codes were assigned a Risk Adjust-
ment for Congenital Heart Surgery-1 classification.
Results: Four hundred ninety-two patients were eligible for analysis, and 279 (57%)
were assigned a Risk Adjustment for Congenital Heart Surgery-1 category. Overall
survival was 42%. In a multivariable logistic regression analysis, significant pre-ex-
tracorporeal predictors for mortality included single-ventricle physiology (odds ratio,
1.6; 95% confidence interval, 1.05–2.4), a history of a stage 1–type procedure (odds
ratio, 2.7; 95% confidence interval, 1.2–6.2), and extreme acidosis (arterial blood gas
pH , 7.01; odds ratio, 2.2; 95% confidence interval, 1.3–3.7). Right carotid artery
cannulation was associated with decreased mortality risk (odds ratio, 0.6; 95% confi-
dence interval, 0.4–0.9). During extracorporeal support, complications, including re-
nal injury, evidence of neurologic injury, and persistent acidosis, were associated with
an increased risk of hospital mortality.
Conclusion: Use of extracorporeal membrane oxygenation as an adjunct to cardio-
pulmonary resuscitation resulted in hospital survival in 42% of infants and children
with heart disease. Underlying cardiac physiology and associated cardiac surgical
procedures influenced mortality, as did pre-extracorporeal resuscitation status and
extracorporeal membrane oxygenation–associated complications.
T
he mainstay for the resuscitation of children after cardiopulmonary arrest has
been conventional cardiopulmonary resuscitation (CPR). However, survival
after CPR has variable results, with recent reports of hospital survival ranging
between 12% and 41%.1,2 There has been an emerging interest in the use of extracor-
poreal membrane oxygenation (ECMO) as a rescue technique (ECPR) for patients in
whom conventional CPR has not re-established a perfusing rhythm and adequate cir-
culation. del Nido and colleagues3 were the first to describe the use of ECPR in in-
fants and children who had previous congenital heart surgery and demonstrated that
the use of ECPR promoted survival in these patients. Patients with congenital heart
disease who have undergone cardiac surgery often have a reversible cause for their
cardiac arrest in the postoperative period and might benefit from ECMO support if
the underlying reason for the cardiac arrest is adequately treated. Infants and children
with congenital heart disease are the largest proportion of patients treated with
ECPR.4
Most reports examining ECPR have been single-institution analyses and have
mainly examined periarrest circumstances, such as duration of chest compressions,
on hospital mortality.4,5 There has been little research examining the effect of specific
cardiac physiology and recent congenital heart surgery on the outcomes of ECMO
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CPR 5 cardiopulmonary resuscitation
CPT 5 Current Procedural Terminology
ECMO 5 extracorporeal membrane oxygenation
ECPR 5 extracorporeal membrane oxygenation to
aid cardiopulmonary resuscitation
ELSO 5 Extracorporeal Life Support Registry
ICD-9 5 International Classification of Diseases–9th
Edition
IQR 5 interquartile range
RACHS-1 5 Risk Adjustment for Congenital Heart
Surgery-1
used as ECPR. Because ECMO programs and therapy are ex-
pensive and considerable institutional resources are needed
to provide rapid deployment of ECMO for ECPR, it is impor-
tant to understand the factors that influence mortality in this
patient group that heavily uses ECPR.
In this study we used data from children with heart disease
who received ECPR as reported to the Extracorporeal Life
Support Registry (ELSO). This was a secondary analysis
from a larger dataset examining ECPR outcomes in all chil-
dren, irrespective of heart disease status.6 Our goal was to de-
termine whether outcomes for these children were associated
with patient demographics, pre-ECMO management, type of
cardiac disease, and ECMO support variables.
Materials and Methods
The ELSO registry contains voluntarily submitted data on infants,
children, and adults who have undergone extracorporeal cardiopul-
monary support at one of 140 international contributing ECMO
centers. Each ECMO center submits data through standardized
ECMO data sheets that contain patient demographics, primary and
secondary diagnoses and procedures, ECMO techniques and com-
plications, and patient hospital survival. ELSO defines ECPR as
‘‘Extracorporeal Cardiopulmonary Resuscitation, in which ECLS
(extracorporeal life support) was used as part of the initial resuscita-
tion from cardiac arrest. Patients who are hemodynamically unstable
and placed on ECLS emergently without a cardiac arrest are not
considered E-CPR.’’ Patients who used ECMO to aid CPR are
specifically coded and can be identified from the ELSO data
registry.
We selected patients with a primary or secondary diagnosis of
cardiac disease from patients who received ECPR during 1992–
2005 and were less than 18 years of age by using their primary
and secondary diagnosis (International Classification of Diseases–
9th Edition [ICD-9]7) and procedure codes (Current Procedural Ter-
minology [CPT]8). Subjects were divided into one of 3 diagnostic
categories based on cardiac disease—single-ventricle lesions, 2-
ventricle lesions including primary pulmonary hypertension, and
cardiac muscle disease (cardiomyopathy or myocarditis)—by using
ICD-9 diagnosis codes and based on their physiology at the time of
ECPR use. Heart transplantation was classified as muscle disease,
and arrhythmias without other structural anomalies reported wereThe Journal of Thoalso classified as cardiac muscle disease. Patients were classified
by 3 independent authors (TC, SLB, RRT), and disagreements
were resolved by a fourth opinion (DF). Any patient in whom con-
sensus on a diagnostic category could not be achieved was excluded
from the analysis (n 5 10).
Additionally, patients who had undergone congenital heart sur-
gery procedures were placed into 6 procedural complexity-based
categories by using the Risk Adjustment for Congenital Heart Sur-
gery-1 (RACHS-1) method.9 The RACHS-1 is a method of risk ad-
justment for in-hospital mortality that accounts for surgical
complexity. Increasing RACHS-1 categories are associated with in-
creasingly complex surgical procedures and increasing risk of in-
hospital mortality. RACHS-1 categories were assigned based on
available CPT codes. The RACHS-1 categories were assigned based
on the highest-risk procedure reported if multiple CPT codes were
available.
Information regarding patient demographics, pre-ECMO sup-
port modalities, pre-ECMO blood gas data, ECMO techniques
and complications, and survival to hospital discharge was evaluated.
Low pH before ECMO has previously been reported to be associ-
ated with mortality.6 Blood gas pH was trichotomized based on
pH data of subjects who died, with the ‘‘lowest’’ pH being less
than the 25th quartile, the ‘‘medium’’ pH determined by the 25th
quartile, and the median value and the ‘‘higher’’ pH being greater
than the median value. Modes of ECMO were classified into veno-
venous, venoarterial, or combination groups if an additional drain-
age or infusion site was used. Arterial cannulation was classified
into one of 3 groups: right carotid, aorta, and ‘‘other,’’ which
included femoral artery and left carotid artery cannulation.
ECMO complications were classified by using complication co-
des created by the ELSO registry for reporting complication-related
information to the registry. These included complications classified
by systems, as well as subgroupings within each systems group. The
complications were grouped as follows: (1) brain injury (seizures
[clinical or electroencephalographic evidence of seizures] and radio-
logic evidence of central nervous system injury [ultrasonographic or
computed tomographic scan evidence of hemorrhage or infarction]);
(2) renal injury (serum creatinine value.1.5 mg/dL and dialysis use
[hemodialysis or continuous arteriovenous hemodialysis]); (3)
bloodstream infection defined as blood culture–proved infection;
(4) ECMO support (arterial blood pH, 7.2 on ECMO, mechanical
failure of ECMO circuit, and cannulation site or surgical site bleed-
ing); (5) respiratory complications (pulmonary hemorrhage and
pneumothorax requiring treatment); (6) cardiac complications (ar-
rhythmias during ECMO support that required treatment and CPR
during ECMO support); and (7) gastrointestinal complications (gas-
trointestinal hemorrhage and hyperbilirubinemia defined as serum
direct bilirubin level .2 mg/dL, indirect bilirubin level .13 mg/
dL, or total bilirubin level .15 mg/dL).
Only 1 ECMO run for each patient was included in the analysis.
For patients who had more than 1 ECMO run (n 5 12), the first
ECMO run was included in the analysis. Demographics, pre-
ECMO data, ECMOdata, and ECMO complications were compared
between survivors and nonsurvivors. The c2 test or the Fisher test
were used for dichotomous data. The Student t test and analysis of
variance tests were used to compare normally distributed continuous
data, whereas the Wilcoxon–Mann–Whitney test and the Kruskal–
Wallis analysis of variance were used for comparison of skewedracic and Cardiovascular Surgery c Volume 136, Number 4 985
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Ddata. Data are presented as mean values with the standard deviation
or median values with the interquartile range (IQR; 25th and 75th
quartiles).
To determine whether cardiac diagnostic categories were inde-
pendently associated with survival after ECPR, a multivariable lo-
gistic regression model was developed. Factors associated with
hospital death were evaluated for inclusion in the multivariable
models by using the cardiac diagnostic groups. A P value of less
than .10 in the bivariable analysis was required for consideration
of inclusion in the multivariable model. An iterative forward selec-
tion process was used for variable entry, with the criterion for inclu-
sion being a P value of less than .05, and the criterion for exclusion
being a P value of greater than .10. Patients with 2 ventricles served
as the reference group. The majority of variables were included as
dichotomous variables, whereas other variables were trichotomized
into ordinal variables by using one category as a referent. For arterial
cannulation, aortic cannulation was used as the reference group,
with right carotid cannulation and all other sites as comparators.
Overfitting was avoided by limiting the number of variables to N/
10 in each model. Another model using RACHS-1 categories rather
than the cardiac diagnosis groups was also developed for the patients
in whom a RACHS-1 classification was possible. Finally, a model
was constructed examining ECMO complications, irrespective of
anatomic classification or RACHS-1 categories, for factors associ-
ated with death after ECPR initiation. Survival was defined as
survival to hospital discharge to either home or another facility. A
c-statistic was computed for each model as a measure of goodness
of fit. Stata 9.2 software (Stata Corp LP, College Station, Tex)
was used for the analysis.
Results
Study Population
Six hundred eighty-two patients underwent ECPR from
1992–2005. Of these, 514 ECMO runs were associated
with underlying heart disease. Of these ECMO runs, 12
were excluded as being repeat ECMO runs. Among the pa-
tients who underwent more than 1 ECMO run, mortality
was 50%. There were 3 patients with single-ventricle lesions
(2 survived), 7 patients with 2-ventricle lesions (4 survived),
and 2 patients with muscle disease (none survived). An addi-
tional 10 patients were excluded because of lack of consensus
regarding diagnostic classification, leaving 492 patients eligi-
ble for analysis (78% of all ECPR pediatric patients). From
this cohort, 285 patients had cardiac surgical procedure co-
des, and 279 patients had sufficient data in the registry for
RACHS-1 category assignment (57% of all cardiac patients).
The median age of the study population was 80 days (IQR,
12–452 days), and the median weight was 4.3 kg (IQR,
3.2–9.5 kg; Table 1). The distribution of diagnostic classifi-
cations included single-ventricle lesion (n 5 196, 40%),
2-ventricle lesion (n 5 186, 38%), and muscle disease (n 5
110, 22%). The RACHS-1 classification included category
1 (n 5 5, 2%), category 2 (n 5 34, 12%), category 3 (n 5
134, 48%), category 4 (n 5 28, 10%), and category 6 (n 5
78, 28%). No RACHS-1 category 5 procedures were
assigned in the study sample.986 The Journal of Thoracic and Cardiovascular Surgery c OctDemographic Information
The total number of ECPR cases used in cardiac patients in-
creased from 57 between the years 1992–1999 to 256 during
2002–2005. Patients with single-ventricle lesions (median
age, 16 days) were younger than patients with 2-ventricle le-
sions (median age, 105 days), with 60% of the single-ventri-
cle group being less than 1 month of age. Conversely,
patients with muscle disease (median age, 710 days) were
older than patients in both the single- and 2-ventricle groups.
Fifty-five percent of patients with muscle disease were older
than 1 year. Patients with muscle disease had equal sex dis-
tribution, whereas a larger proportion of male children were
present in both the single-ventricle (60%) and 2-ventricle
(64%) groups. There was also an equal distribution of pa-
tients with muscle disease into white and nonwhite cate-
gories, whereas the single-ventricle (62%) and 2-ventricle
(65%) groups had a higher proportion of white patients.
Patients who survived to hospital discharge or transfer are
compared with those who died in Table 1. Overall survival
was 42%. Patients with single-ventricle lesions had a lower
survival rate compared with that of patients with 2-ventricle
lesions (P5 .02, c2 test), whereas there was no difference in
survival between those with 2-ventricle lesions and those
with muscle disease (P 5 .6, c2 test) or between those with
single-ventricle lesions and those with muscle disease (P 5
.1, c2 test). As expected, higher RACHS-1 categories were
associated with lower rates of survival among subjects for
whom a RACHS-1 category could be assigned (P 5 .003,
trend test). There were no differences in age, weight, or
year of ECMO treatment between survivors and nonsurvi-
vors. There was a nonsignificant trend toward lower survival
among nonwhite patients compared with white patients (37%
vs 46%, P 5 .07).
Pre-ECMO and ECMO Support Information
The ELSO data include information on ventilator settings and
respiratory support information immediately before ECPR.
This includes the worst arterial blood gas recorded in the 6
hours before the initiation of ECMO. There were no differ-
ences in ventilator settings and use of other respiratory mo-
dalities between survivors and nonsurvivors, with the
exception of the mean airway pressure, which was higher
among survivors (Table 2). Survivors tended to have a shorter
time period of mechanical ventilation before the initiation of
ECMO compared with nonsurvivors. Median pre-ECMO
blood gas values were similar between survivors and nonsur-
vivors. When blood gas pH measurements were trichotom-
ized, there was a higher proportion of nonsurvivors with
a pH of less than 7.01 before ECPR (P 5 .001, individual
c2 test).
Table 2 also includes immediate ECMOmanagement fea-
tures. The vast majority of survivors and nonsurvivors were
treated with venoarterial ECMO (93% vs 91%, respectively),
with a small proportion being managed with a combinationober 2008
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Dmode or venovenous ECMO. Although there was no differ-
ence in mortality among all sites of arterial cannulation, pa-
tients who underwent right carotid cannulation had a lower
mortality rate when compared with those undergoing aortic
cannulation (52% vs 62%, P5 .03). There was no difference
in starting flow rate on ECMO or hours on ECMO between
survivors and nonsurvivors.
ECMO Complications
Surviving patients had a longer hospital length of stay com-
pared with those who died. The median hospital length of
stay was 37 days (IQR, 22–62 days) versus 14 days (IQR,
6–28 days) for survivors and nonsurvivors (P , .001, Wil-
coxon–Mann–Whitney test). A number of ECMO complica-
tions were associated with increased mortality (Table 3).
Radiologic evidence of central nervous system injury, renal
injury (defined as a serum creatinine level .1.5 mg/dL),
use of renal replacement therapy, arterial blood gas pH of
less than 7.2 during ECMO, pulmonary and gastrointestinal
hemorrhage, hyperbilirubinemia, and requirement for CPR
during ECMO were all associated with increased mortality,
whereas the presence of seizures, bloodstream infections,
pneumothorax, mechanical failure of the ECMO pump,
bleeding from the cannulation site, and arrhythmias during
ECMO were not associated with in-hospital death.
ECMO can be used as a bridge to heart transplantation.
Thirty patients in this study received a heart or heart–lung
transplantation, and patients with muscle disease comprised
the majority of this subgroup (80%). Among transplant recip-
ients, 17 (57%) children survived.
Multivariable Analysis of Factors Associated With
Mortality
Two separate multivariable models were constructed to de-
termine pre-ECMO variables associated with death. One
model included pre-ECMO variables and cardiac diagnostic
classification, whereas another used RACHS-1 categories
and pre-ECMO variables. These models are presented in Ta-
ble 4. Both models found cannulation of the right carotid ar-
tery to be associated with lower mortality. In the model based
on cardiac diagnosis classification, an arterial blood gas pH
of less than 7.01 increased the odds of mortality (odds ratio,
2.2; 95% confidence interval, 1.3–3.7) adjusted for cardiac
diagnosis and cannulation site. Patients with single-ventricle
lesions had increased odds of mortality compared with chil-
dren with 2-ventricle lesions or pulmonary hypertension
(odds ratio, 1.6; 95% confidence interval, 1.05–2.4; single-
variable P 5 .03) adjusted for both cannulation site and
pH. Similarly, children with RACHS-1 category 6 proce-
dures had increased odds of mortality compared with patients
TABLE 1. Selected demographic features of subjects comparing survivors and nonsurvivors
Characteristic Survivors (n 5 208) Nonsurvivors (n 5 284) Statistical test, P value
Cardiac diagnosis, n (%) Fisher exact test, .05y
One ventricle 70 (36%) 126 (64%)
Two ventricles/ pulmonary hypertension 89 (48%) 97 (52%)
Muscle disease 49 (45%) 61 (55%)
Age, d (median [IQR]) 82 (12–442) 77 (14–1092) Wilcoxon–Mann–Whitney, .6
Weight, kg (median [IQR]) 4.4 (3.2–8.8) 4.3 (3.1–10) Wilcoxon–Mann–Whitney, .6
Sex, n (%) c2 test, .8y
Male 124 (43%) 166 (57%)
Female 83 (41%) 117 (59%)
Missing 1 (50%) 1 (50%)
Race, n (%) c2, .07
White 135 (46%) 161 (54%)
Other 73 (37%) 123 (63%)
ECPR year, n (%) c2, .5y
1992–1999 26 (46%) 31 (54%)
2000–2002 70 (39%) 109 (61%)
2003–2005 112 (44%) 144 (56%)
RACHS-1,* n (%) Trend test, .003y
1 2 (40%) 3 (60%)
2 18 (53%) 16 (47%)
3 63 (47%) 71 (53%)
4 10 (36%) 18 (64%)
5 0 0
6 22 (28%) 56 (72%)
IQR, Interquartile range; ECPR, extracorporeal membrane oxygenation to aid cardiopulmonary resuscitation; RACHS-1, Risk Adjustment for Congenital Heart
Surgery-1. *n 5 279. yDenotes global test for significance.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 4 987
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95% confidence interval, 1.2–5.6) adjusted for cannulation
site. Blood pH before ECPR was not associated with mortal-
ity in this model, which might be due to a smaller sample size
(n5 277). When pH was retained in the model, the adjusted
odds ratio for mortality of RACHS-1 category 6 procedures
compared with categories 1 or 2 was 2.7 (95% confidence
interval, 1.2–6.2).
In a third model examining ECMO complications associ-
ated with death, radiologic evidence of central nervous sys-
tem injury, renal injury, and an arterial blood gas pH of
less than 7.2 during ECMOwere associated with an increased
risk of death. Duration of ECMO was included in the model
because longer periods of ECMO exposed the patients to
a greater duration for ECMO-associated complications. Use
of renal replacement therapy during ECMO, pulmonary hem-
orrhage, and CPR during ECMO were not independently as-
sociated with increased mortality in the multivariable model.
Gastrointestinal bleeding was removed from the model be-
cause it predicted mortality perfectly. Additionally, hyperbi-
lirubinemia tended to be associated with mortality (odds
ratio, 3.5; 95% confidence interval, 0.99–12.6; P 5 .051).
Discussion
In this analysis children with heart disease who underwent
ECMO as an aid to CPR had an overall survival rate of
42%. Patients with single-ventricle lesions and those whose
surgical procedures were assigned a higher surgical complex-
ity category (RACHS-1 category 6) had higher odds of mor-
tality compared with those undergoing less complex repairs.
Severe acidosis before being started on ECMO was also
associated with increased mortality, whereas right carotid
artery cannulation was associated with decreased mortality
odds. During ECMO, persistent acidosis, renal injury, and
central nervous system injury on imaging studies indepen-
dently increased the odds of hospital mortality.
The survival rate after cardiac arrest in children varies sig-
nificantly among different studies and ranges from 12%1 to
TABLE 2. Pre-ECMO support and initial ECMO features
Features Survivors (n 5 208) Nonsurvivors (n 5 284) Statistical test, P value
Ventilatory support,* mm Hg (median [IQR] Wilcoxon–Mann–Whitney
PIP 25 (22–34) 25 (22–30) .3
PEEP 5 (4–7) 5 (4–5) .2
MAP 11 (9–16) 10 (8–12) .04
Arterial blood gas* (median [IQR]) Wilcoxon–Mann–Whitney
PaCO2 (mm Hg) 48 (35–64) 46 (36–68) .9
PaO2 (mm Hg) 46 (32–69) 40 (27–68) .1
pH 7.26 (7.09–7.38) 7.21 (7.01–7.39) .1
Categorized arterial blood gas pH (n [%]) c2, .03y
pH ,7.01 26 (30%) 60 (70%)
pH 7.01–7.21 40 (41%) 58 (59%)
pH .7.21 142 (46%) 166 (54%)
Pre-ECMO therapies (n [%])
iNO 18 (40%) 27 (60%) c2, .7
HFOV 4 (57%) 3 (43%) Fisher exact test, .5
Surfactant 1 (50%) 1 (50%) Fisher exact test, 1
Time from intubation to ECMO, h (median [IQR]) 12 (2–60) 20 (3–97) Wilcoxon–Mann–Whitney, .08
Mode of ECMO, n (%) Fisher–Freeman–Halton, .3y
Venoarterial 193 (43%) 257 (57%)
Venovenous 0 3 (100%)
Combination 14 (37%) 24 (63%)
Missing 1 (100%) 0
Arterial cannulation site, n (%) Fisher exact test, .06y
Right carotid artery 109 (48%) 116 (52%)
Aorta 82 (38%) 134 (62%)
Other 13 (39%) 20 (61%)
Venovenous 0 3 (100%)
Missing 4 (27%) 11 (73%)
Starting flow, mL $ kg21 $ min21 (median [IQR]) 100 (83–124) 107 (84–135) Wilcoxon–Mann–Whitney, .3
Hours on ECMO (median [IQR]) 87 (51–137) 87 (37–171) Wilcoxon–Mann–Whitney, .9
ECMO, Extracorporeal membrane oxygenation; IQR, interquartile range; PIP, peak inspiratory pressure; PEEP, positive end-expiratory pressure; MAP, mean
airway pressure; iNO, inhaled nitric oxide; HFOV, high-frequency oscillatory ventilation. *Missing data: ventilator settings, 59% to 69%; arterial blood gas,
18% to 19%. yDenotes global test for significance.988 The Journal of Thoracic and Cardiovascular Surgery c October 2008
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ative cardiac patients, the hospital discharge rate after cardiac
arrest has been reported to be as low as 12% to 16%.1,10 Con-
versely, in patients with heart disease, survival rates after car-
diac arrest without the use of ECMO are between 38%11 and
41%.2 The overall hospital survival for pediatric patients in
the current study is comparable with that in the latter studies.
Two other studies examining ECPR in children have found
similar hospital survival rates for children with heart dis-
ease.4,12 However, the population of patients in this analysis
and the other reports had failed conventional resuscitative
techniques and likely faced high mortality in the absence of
ECPR. Thus these data suggest that a subset of children
with cardiac disease and persistent cardiac arrest might
have a reversible process, and their survival might be im-
proved by use of short-term mechanical circulatory support
after failure to respond to conventional CPR therapies.
Although the ELSO database does not include informa-
tion regarding neurologic status at hospital discharge and is
a limitation to our study, 2 case series of patients undergoing
ECPR suggest that the majority of patients who survive to
hospital discharge have a favorable outcome.4,12 In the series
by Morris and colleagues,4 half of survivors older than 2
months with follow-up had no decrement in their Pediatric
Cerebral or Overall Performance Category. In a series by Al-
soufi and associates,12 86% of children with cardiac disease
who survived had a grossly intact neurologic status.
In our study, patients with single-ventricle lesions had
lower survival rates than patients with 2-ventricle lesions.
In contrast, a recent case series of patients undergoing
ECPR found patients with single-ventricle lesions to have
a higher survival rate (47%) than patients with 2-ventricle le-
sions (27%).12 This discrepancy might be due to a smaller
sample size (80 patients) in the case series or might be
due to differences in ECMO experience or practice style re-
lated to individual centers. When surveying studies examin-
ing ECMO in association with cardiac surgery, patients with
single-ventricle lesions have not consistently been shown to
have poorer survival when compared with patients with 2-
ventricle lesions.5,13-16 However, the ELSO cumulative
summary for data collected through 2007 reported survival
for infants (age 0–30 days) with hypoplastic left heart syn-
drome to be 26% compared with an overall survival of
36% for infants with any congenital heart disease when sup-
ported by ECMO for cardiac failure.17 Some discrepancy
might be due to differences in classification because some
studies have only classified patients with hypoplastic left
heart syndrome as a single ventricle,14,15 whereas others
have classified any patient with intracardiac mixing of sys-
temic and pulmonary blood return as a single ventricle. It
is also possible that the subset of patients with cardiac dis-
ease undergoing ECPR are different from the larger popula-
tion of patients with cardiac disease who are started on
ECMO for reasons other than cardiac arrest (low cardiac
output states, unable to separate from bypass, and respira-
tory failure) and that key differences in this subset might
be the reason behind decreased survival of patients with sin-
gle-ventricle lesions.
TABLE 3. ECMO complications and hospital survival
Characteristic Survivors (n 5 208), n (%) Nonsurvivors (n 5 284), n (%) Statistical test, P value
Neurologic, n (%) c2
Seizures 25 (42%) 34 (58%) 1
Radiologic evidence of CNS injury 10 (19%) 42 (81%) ,.001
Renal, n (%) c2
Creatinine .1.5 mg/dL 24 (27%) 64 (73%) .002
Renal replacement therapy 11 (26%) 32 (74%) .02
Bloodstream infection, n (%) 14 (33%) 28 (67%) c2, .2
ECMO support, n (%) c2
pH ,7.2 on ECMO 9 (18%) 40 (82%) ,.001
Mechanical failure 19 (33%) 39 (67%) .1
Cannula bleeding 60 (40%) 91 (60%) .4
Respiratory, n (%)
Pulmonary hemorrhage 9 (24%) 28 (76%) c2, .02
Pneumothorax 0 5 (100%) Fisher exact test, .08
Gastrointestinal, n (%)
Gastrointestinal bleed 0 7 (100%) Fisher exact test, .02
Hyperbilirubinemia 3 (12%) 22 (88%) c2, .002
Cardiac, n (%) c2
Arrhythmias on ECMO 33 (36%) 59 (64%) .2
CPR on ECMO 7 (24%) 22 (76%) .04
ECMO, Extracorporeal membrane oxygenation; CNS, central nervous system; CPR, cardiopulmonary resuscitation.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 4 989
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DIn our study, patients with cardiomyopathy or myocardi-
tis who were started on ECPR did not have a significantly
different rate of survival when compared with postoperative
cardiac patients. Additionally, the hospital survival rate of
patients with cardiac muscle disease in the present patient
population (45%) was lower than that in other studies that
have examined survival among patients with cardiomyopa-
thy or myocarditis supported with ECMO. In a study by
McMahon and coworkers,18 children with dilated cardiomy-
opathy started on ECMO had a hospital survival rate of
89%, with the majority of survivors (71%) being bridged
to heart transplantation by means of ECMO. Similarly, pa-
tients with myocarditis supported with ECMO had a survival
rate of 83%, although this did include some patients who
underwent a cardiac arrest.19 Alsoufi and associates12
reported higher survival rates for patients with cardiomyop-
athy (50%) and myocarditis (67%) compared with postcar-
diotomy patients (36%) when started on ECMO for
ECPR, although these survival rates are still lower than
the survival rates of patients with cardiac muscle disease
started on ECMO for circulatory support, which might be
related in part to organ availability for transplantation within
the limited time of ECMO support. The disparity in survival
might also stem from having a cardiac arrest. In patients
with heart failure and compromised circulation, an arrest
event would likely worsen their circulatory status and nega-
tively affect survival. Alternatively, a cardiac arrest in pa-
tients with muscle disease might be a sign of rapidly
deteriorating circulatory status, and thus these patients might
have a poorer clinical status when compared with patients
with cardiac muscle disease who have not had a cardiac ar-
rest. Regardless of the underlying cause for this discrepancy
in survival rates, supporting patients with cardiomyopathy
or myocarditis with ECMO before an arrest appears to be as-
sociated with improved survival compared with those
treated for arrest.
In our study, a low blood gas pH was associated with de-
creased survival. Without the use of ECPR, several factors
during cardiac arrest, including prolonged resuscitation
times,10 administration of bicarbonate,2,10 and administration
TABLE 4. Features associated with death in children with cardiac disease undergoing ECPR
Variable Odds ratio P value 95% confidence interval
Pre-ECMO factors
Model 1: Diagnostic classification* (n 5 492) .09
Two ventricles/pulmonary hypertension 1.0 Reference group
One ventricle 1.6 1.05–2.4
Muscle disease 1.2 0.7–1.9
Pre-ECMO arterial blood pH .01
pH .7.21 1.0 Reference group
pH 7.01–7.21 1.3 0.8–2.1
pH ,7.01 2.2 1.3–3.7
Arterial cannulation site .03
Aorta 1.0 Reference group
Right carotid artery 0.6 0.4–0.9
Other sites 1.2 0.6–2.3
Model 2: RACHS-1 scorey (n 5 277) .02
RACHS 1–2 1.0 Reference group
RACHS 3–5 1.3 0.6–2.7
RACHS 6 2.7 1.2–6.2
Pre-ECMO arterial blood pH .09
pH .7.21 1.0 Reference group
pH 7.01–7.21 1.8 0.9–3.5
pH ,7.01 1.9 0.9–4.0
Arterial cannulation site .02
Aorta 1.0 Reference group
Right carotid artery 0.5 0.3–0.8
Other sites 1.3 0.5–3.6
ECMO complicationsz (n 5 485)
CNS injury on radiology 3.7 ,.001 1.8–7.6
Renal injury 1.8 .03 1.1–3.1
Days on ECMO 1.0 .04 1.0–1.08
pH ,7.2 during ECMO 3.5 .001 1.6–7.6
ECPR, Extracorporeal membrane oxygenation as an aid to cardiopulmonary resuscitation; ECMO, extracorporeal membrane oxygenation; RACHS-1, Risk
Adjustment for Congenital Heart Surgery-1; CNS, central nervous system. *c-statistic 5 0.62. yc-statistic 5 0.66. zc-statistic 5 0.63.990 The Journal of Thoracic and Cardiovascular Surgery c October 2008
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Dof high doses of epinephrine,2,10 have been associated with
decreased survival. Resuscitation time and drugs adminis-
tered before initiation of ECPR are not recorded in the
ELSO database. The blood gas pH was used as a proxy mea-
sure for determining adequacy and duration of CPR because
patients with an extreme acidosis likely had inadequate or
longer duration of resuscitation before implementation of
ECPR. Other studies examining ECPR have produced mixed
results regarding an association between length of CPR and
hospital survival among patients with heart disease.4,5,12,13
In fact, the majority of these studies have not found a differ-
ence in CPR duration among survivors and nonsurvi-
vors.4,5,12 This might suggest that the quality of CPR might
be more important than the duration of CPR. It might be
for this reason that no upper limit of duration of pre-ECMO
CPR for withholding ECPR has been established. Similarly,
because 30% of patients with a blood gas pH of less than 7.01
still survived to hospital discharge, a lower blood gas pH
limit for withholding ECPR cannot be delineated. However,
pre-ECMO arterial blood pH along with other markers of or-
gan injury might help clinical decision making regarding
continued ECMO support.5 Blood pH might also be used
as an indirect measure of the pre-ECMO and prearrest circu-
latory status. From this standpoint, a low blood pH in a patient
who is receiving maximal medical therapy might be an indi-
cation for urgent ECMO support before cardiac arrest.
It is notable that right carotid cannulation was associated
with increased survival. It is likely that children who were
cannulated through the right carotid artery had a closed chest,
whereas children cannulated through the aorta likely had an
open chest or were in the early postoperative period.5 Thus
right carotid artery cannulation is probably an indirect index
of clinical stability after surgical intervention. Additionally,
aortic cannulation can be technically more difficult with
more significant complications, such as tamponade and can-
nula dislodgement. The cannulation site might also be reflec-
tive of differences in center practice. ELSO does not release
center-related data, and we were unable to adjust for this po-
tential confounder. Finally, children with 2-ventricle lesions
and cardiac muscle disease were significantly more likely to
be cannulated through the right neck when compared with
those with single-ventricle lesions, and although this was in-
cluded in the analysis, it is possible that this colinearity was
not fully accounted for in the logistic regression. The associ-
ation between neck cannulation and increased survival was
not found in a recent report of ECPR use in children with
heart disease.12 This might be due to a smaller number of pa-
tients in their report when compared with our current cohort
or possibly because of variability in institutional practice and
experience regarding the choice of ECMO cannulation site.
Several ECMO complications, including renal injury,
neurologic injury, and persistent acidosis after the initiation
of ECMO, were found to be significantly associated with de-
creased hospital survival. Similar to our findings, other stud-The Journal of Thoies consistently report that renal injury,5,13,15,16,20,21
neurologic injury,15 and increasing time on ECMO13,16 are
associated with decreased survival. Use of renal replacement
therapy was not independently associated with increased
mortality likely caused by colinearity with renal injury. In
a study by Huang and colleagues,16 higher lactate levels dur-
ing ECMO were associated with decreased survival. Al-
though the ELSO database does not report lactate levels,
persistent acidosis during ECMO was associated with de-
creased survival in our study. This suggests that persistent in-
sufficient circulatory support on ECMO is a poor prognostic
factor. In this current cohort, hepatic failure, as evidenced by
hyperbilirubinemia, tended to be associated with decreased
survival. Although not as prevalent as renal injury in other
studies, liver failure has also been described as a risk factor
for poor hospital survival.5 Other factors that had been previ-
ously associated with decreased survival but not confirmed in
this study included serious circuit complications,20 age, and
male sex.5
There are several limitations of this study. Although the
definition of ECPR has been delineated and generally ac-
cepted as receiving chest compressions while being cannu-
lated for ECMO, the classification of ECPR is dependent
on each institution’s voluntary submission of data and coding
accuracy. Similarly, the accuracy of information regarding
diagnosis and procedures is dependent on the accuracy of
each institution. The ELSO registry provides definitions for
ICD-9 codes, as well as CPT codes, in the forms provided
to ELSO members.22 Although ELSO does conduct audits
by asking institutions to resubmit information for a sample
of patients, it does not independently verify submitted infor-
mation. It is only recently that ELSO began collecting infor-
mation regarding operative details of patients undergoing
cardiac surgery. This information is currently not available
for analysis and limits information regarding surgical inter-
vention and timing of ECMO support. The ELSO database
contains all operative procedures that a patient had during
the hospitalization when he or she underwent ECMO but
not when these procedures occurred. No details of the tempo-
ral relationship between each operation and the patient’s
ECMO run are available. When assigning RACHS-1 scores,
the highest RACHS-1 score assignable was given with the as-
sumption that the patient was started on ECMO after the most
complicated procedure. It is possible that patients undergoing
cardiac surgery could arrest and be placed on ECMO before
this surgical procedure. With a few exceptions, it is more
likely that patients would arrest after heart surgery rather
than before a procedure. There is also the possibility of mis-
classification bias caused by the heterogeneity of the diagno-
ses listed for each patient. Some patients in the ELSO
database had multiple diagnoses that included cardiac disease
among others. Although one would expect patients with con-
genital heart disease to arrest for cardiac reasons, it is possible
for these patients to arrest as a result of other causes, such asracic and Cardiovascular Surgery c Volume 136, Number 4 991
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Drespiratory disease, toxic ingestions, or sepsis. Using the cur-
rent ELSO database, it is not possible to discriminate between
concurrent illnesses and the immediate cause of an arrest.
Conclusion
We found that ECMO used as a rescue therapy for CPR was
associated with survival in more than 40% of patients who
faced a high likelihood of death without mechanical support.
In this group single-ventricle physiology or those undergoing
more complex cardiac surgery had decreased odds of sur-
vival. Additionally, pre-ECMO acidosis was also associated
with decreased survival, stressing the importance of adequate
CPR and rapid deployment of ECPR, as well as consideration
of using ECMO before an arrest in a clinically deteriorating
patient. Finally, evidence of renal injury, central nervous sys-
tem injury, and persistence of inadequate systemic perfusion
during ECMOwere predictors of poor survival once a patient
was started on ECMO.
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